Vipul Jain, MD, MS

Title(s)Professor, Dean's Office
SchoolSchool of Medicine
Address155 N Fresno St
Fresno CA 93701
Phone559-499-6400
ORCID ORCID Icon0000-0001-5575-7869 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency

    Collapse Overview 
    Collapse Overview
    Vipul Jain, M.D.
    Professor of Clinical Medicine, UCSF
    Executive Vice Chair
    Interim Division Chief, Pulmonary, Critical Care and Sleep Medicine
    Director, Smoking Cessation Program, UCSF Fresno

    Vipul Jain, M.D., specializes in pulmonary & critical care medicine. He is board certified in internal medicine, pulmonary and critical care medicine.

    Dr. Jain completed his internal medicine residency at UCSF Fresno and a fellowship in pulmonary and critical care medicine at the University of California, San Diego.

    Dr. Jain is a member of the American College of Physicians and the Society of Critical Care Medicine.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A single home visit improves adherence and reduces healthcare utilization in patients with frequent exacerbations of Severe Asthma and COPD. Respiratory Medicine X. 2021 Nov 1; 3:100026. Ghimire GA, Allison AR, Lichtemberg LY, Vempilly VJ, Jain JV. .
      View in: Publisher Site   Mentions:
    2. Residual Volume Responsiveness Testing May Improve the Detection of Reversible Airway Obstruction in Asthma. J Allergy Clin Immunol Pract. 2022 01; 10(1):250-256. Vempilly JJ, Rashidian A, Jain VV, Abejie BA, Bhakta N. PMID: 34536615.
      View in: PubMed   Mentions:    Fields:    
    3. Reducing Tobacco-Related Disability in Chronic Smokers. Am J Med. 2020 08; 133(8):908-915. Ambrose JA, Najafi A, Jain V, Muller JE, Ranka S, Barua RS. PMID: 32325048.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    4. Air Trapping Correlates With Increased Frequency of Albuterol Use and Severity of Wheeze in Persistent Asthma. Respir Care. 2020 Jul; 65(7):994-1000. Vempilly JJ, Abejie BA, Rashidian A, Jain VV, Bhakta N. PMID: 32019852.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Metoprolol for the Prevention of Acute Exacerbations of COPD. N Engl J Med. 2019 12 12; 381(24):2304-2314. Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoglu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE, BLOCK COPD Trial Group. PMID: 31633896; PMCID: PMC7416529.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    6. Ability of Exhaled Nitric Oxide to Discriminate for Airflow Obstruction Among Frequent Exacerbators of Clinically Diagnosed Asthma. Lung. 2018 08; 196(4):455-462. Jalota L, Allison DR, Prajapati V, Vempilly JJ, Jain VV. PMID: 29916097.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. True Negative Predictive Value of Preoperative Staging Endosonography by Combined Endobronchial Ultrasound and Endoscopic Ultrasound in Non-Small Cell Lung Cancer. CHEST Journal. 2017 Oct 1; 152(4):a860. Hegde HP, Thiffault TV, Jain JV, Gowda GA, Ferraro FP, Liberman LM. .
      View in: Publisher Site   Mentions:
    8. Pulmonary Rehabilitation Maintenance Program May Prevent Accelerated FEV1 Decline in Patients With COPD. Clinical Pulmonary Medicine. 2017 Jul 1; 24(4):143-148. Andrews AS, Deoghare DH, Mills MP, Van Gundy VK, Vempilly VJ, Jain JV. .
      View in: Publisher Site   Mentions:
    9. Reassessment of an Asthma Diagnosis. JAMA. 2017 05 02; 317(17):1801-1802. Jain VV, Stringer W. PMID: 28464136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Longer duration of asthma is significantly associated with increased RV/TLC ratio. Respir Med. 2017 03; 124:44-48. Tiwari A, Rahman K, Abejie B, Jain VV, Vempilly JJ. PMID: 28284320.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Pulmonary Fellows and the 2-Tube Approach for Mediasinal Staging of Non-small Cell Lung Cancer. CHEST Journal. 2016 Oct 1; 150(4):977a. Nat NA, Jain JV, Upadhyay UD, Peterson PM, Hegde HP. .
      View in: Publisher Site   Mentions:
    12. A Single Home Visit Improves Patient Adherence and Reduces Exacerbations in Patients With Severe Asthma and COPD. CHEST Journal. 2016 Oct 1; 150(4):15a. Allison AD, Van Gundy VK, Vempilly VJ, Jain JV. .
      View in: Publisher Site   Mentions:
    13. Residual Volume Reversibility Is a Better Test in Identifying Reversible Airway Disease Compared to FEV1 Reversibility in Patients With Chronic Persistent Asthma. CHEST Journal. 2016 Oct 1; 150(4):919a. Sazgar SS, Rashidian RA, Abejie AB, Jain JV, Vempilly VJ. .
      View in: Publisher Site   Mentions:
    14. Action plans for COPD: strategies to manage exacerbations and improve outcomes. Int J Chron Obstruct Pulmon Dis. 2016; 11:1179-88. Jalota L, Jain VV. PMID: 27330286; PMCID: PMC4898028.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Office spirometry correlates with laboratory spirometry in patients with symptomatic asthma and COPD. Clin Respir J. 2017 Nov; 11(6):805-811. Bambra G, Jalota L, Kapoor C, Mills PK, Vempilly JJ, Jain VV. PMID: 26620598.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    16. Lung Volume Reversibility Testing Improves Diagnostic Yield of Bronchodilator Response in Asthma. CHEST Journal. 2015 Oct 1; 148(4):663a. Rashidian RA, Sazgar SS, Mejia MJ, Tyner TT, Abejie AB, Jain JV, Vempilly VJ. .
      View in: Publisher Site   Mentions:
    17. Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction. Lung. 2015 Aug; 193(4):505-12. Jain VV, Allison DR, Andrews S, Mejia J, Mills PK, Peterson MW. PMID: 25921015.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Lung Volume Indices Correlate Better With the Duration of Asthma Than Spirometry. CHEST Journal. 2014 Oct 1; 146(4):15a. Rahman RK, Tiwari TA, Abejie AB, Jain JV, Joseph JJ. .
      View in: Publisher Site   Mentions:
    19. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD. Respir Med. 2014 Dec; 108(12):1794-800. Jain VV, Allison R, Beck SJ, Jain R, Mills PK, McCurley JW, Van Gundy KP, Peterson MW. PMID: 25294691.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    20. Lung volume abnormalities and its correlation to spirometric and demographic variables in adult asthma. J Asthma. 2013 Aug; 50(6):600-5. Jain VV, Abejie B, Bashir MH, Tyner T, Vempilly J. PMID: 23521185.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Costimulation and allergic responses: immune and bioinformatic analyses. Pharmacol Ther. 2008 Mar; 117(3):385-92. Jain VV, Perkins DL, Finn PW. PMID: 18280573.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    22. Hubs in biological interaction networks exhibit low changes in expression in experimental asthma. Mol Syst Biol. 2007; 3:98. Lu X, Jain VV, Finn PW, Perkins DL. PMID: 17437023; PMCID: PMC1865580.
      View in: PubMed   Mentions: 48     Fields:    Translation:Animals
    23. Immunomodulation of allergic responses by targeting costimulatory molecules. Curr Opin Allergy Clin Immunol. 2006 Dec; 6(6):489-94. Jen KY, Jain VV, Makani S, Finn PW. PMID: 17088657.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    24. NEUROLOGIC SEQUELAE OF SUBCLAVIAN VEIN CATHETERIZATION. Critical Care Medicine. 2006 Dec 1; 34(12):a168. Jain JV, Bigby BT. .
      View in: Publisher Site   Mentions:
    25. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area. Respir Med. 2006 Jul; 100(7):1291-3. Jain VV, Evans T, Peterson MW. PMID: 16545951.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    26. CpG DNA: immunomodulation and remodelling of the asthmatic airway. Expert Opin Biol Ther. 2004 Sep; 4(9):1533-40. Jain VV, Kline JN. PMID: 15335319.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    27. Effect of nitrogen dioxide exposure on allergic asthma in a murine model. Chest. 2004 Jul; 126(1):198-204. Hussain I, Jain VV, O'Shaughnessy P, Businga TR, Kline J. PMID: 15249463.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    28. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol Lung Cell Mol Physiol. 2003 Nov; 285(5):L1137-46. Jain VV, Businga TR, Kitagaki K, George CL, O'Shaughnessy PT, Kline JN. PMID: 12857672.
      View in: PubMed   Mentions: 18  Translation:AnimalsCells
    29. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol. 2002 Dec; 110(6):867-72. Jain VV, Kitagaki K, Businga T, Hussain I, George C, O'shaughnessy P, Kline JN. PMID: 12464952.
      View in: PubMed   Mentions: 34     Fields:    Translation:Animals
    30. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin Diagn Lab Immunol. 2002 Nov; 9(6):1260-9. Kitagaki K, Jain VV, Businga TR, Hussain I, Kline JN. PMID: 12414759; PMCID: PMC130087.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    31. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides. Laryngoscope. 2002 Oct; 112(10):1819-26. Hussain I, Jain VV, Kitagaki K, Businga TR, O'Shaughnessy P, Kline JN. PMID: 12368622.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCellsPHPublic Health
    32. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am J Physiol Lung Cell Mol Physiol. 2002 Jul; 283(1):L170-9. Kline JN, Kitagaki K, Businga TR, Jain VV. PMID: 12060574.
      View in: PubMed   Mentions: 30  Translation:AnimalsCells
    Vipul's Networks
    Concepts (158)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (10)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California